Insider Transactions in Q1 2022 at Axcella Health Inc. (AXLA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,535
+0.93%
|
-
|
|
Mar 16
2022
|
Robert Crane Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
39,267
+50.0%
|
$39,267
$1.91 P/Share
|
|
Mar 16
2022
|
David R Epstein Director |
BUY
Open market or private purchase
|
Direct |
26,178
+13.97%
|
$26,178
$1.91 P/Share
|
|
Mar 16
2022
|
Paul Fehlner SVP & Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
10,471
+33.48%
|
$10,471
$1.91 P/Share
|
|
Mar 16
2022
|
William Hinshaw President & CEO |
BUY
Open market or private purchase
|
Direct |
13,089
+21.42%
|
$13,089
$1.91 P/Share
|
|
Mar 16
2022
|
Flagship Ventures Fund Iv General Partner LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,319,371
+29.61%
|
$6,319,371
$1.91 P/Share
|
|
Mar 16
2022
|
Societe Des Produits Nestle S.A. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,141,361
+29.67%
|
$3,141,361
$1.91 P/Share
|
|
Mar 01
2022
|
Margaret Koziel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
553
-2.03%
|
$553
$1.86 P/Share
|
|
Feb 18
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,534
+1.12%
|
-
|
|
Jan 31
2022
|
William Hinshaw President & CEO |
SELL
Open market or private sale
|
Direct |
16,590
-33.18%
|
$16,590
$1.65 P/Share
|
|
Jan 28
2022
|
William Hinshaw President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
-
|
|
Jan 18
2022
|
David R Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,535
+1.14%
|
-
|